The P2X7 receptor of CLL lymphocytes - A molecule with a split personality

Lancet

Volumn 360, Issue 9349, 2002, Pages 1898-1899

  Di Virgilio, Francesco ^a,b   Wiley, James S ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; PROTEIN BCL 2; PURINE P2X RECEPTOR;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; EARLY DIAGNOSIS; FAMILIAL CANCER; GENE FREQUENCY; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HUMAN; LYMPHOCYTE; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; TUMOR PROMOTION;

EID: 0037079312     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11933-7     Document Type: Note

References (12)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin. 48:1998;6-29.
2. Wickremasinghe R.G., Hoffbrand A.V. Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and haematological malignancies. Blood. 93:1999;3587-3600.
3. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1999;1848-1854.
4. Damle R.N., Wasil T., Fais F., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1999;1840-1847.
5. Di Virgilio F., Chiozzi P., Ferrari D., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood. 97:2001;587-600.
6. Wiley J.S., Dubyak G.R. Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood. 73:1989;1316-1323.
7. Baricordi O.R., Melchiorri L., Adinolfi E., et al. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem. 274:1999;33206-33208.
8. Rassendren F., Buell G.N., Virginio C., Collo G., North R.A., Surprenant A. The permeabilizing ATP receptor, P2X7: cloning and expression of a human cDNA. J Biol Chem. 272:1997;5482-5486.
9. Adinolfi E., Melchiorri L., Falzoni S., et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood. 99:2002;706-708.
10. Wiley J.S., Dao-Ung L.P., Gu B.J., et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet. 359:2002;1114-1119.
11. Gu B.J., Zhang W.Y., Worthington R.A., et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem. 276:2001;11135-11142.
12. Rawstron A.C., Green M.J., Kuzmicki A., et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 100:2002;635-639.